Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 57

Sophia Genetics secures $234m in IPO

Genomics analytics platform developer Sophia Genetics has gone public ten years after it was co-founded by researchers from EMBL, Stanford and University of Geneva

Jul 27, 2021

PropertyGuru to build $1.35bn reverse merger

The REA Group-backed real estate marketplace is set to carry out a reverse takeover at a $1.35bn valuation almost two years after it withdrew its attempt to float in Australia.

Jul 27, 2021

Outbrain counts up $160m in IPO

The Gruner + Jahr and Susquehanna International Group-backed content recommendation engine developer floated below its range but is slightly up from its IPO price.

Jul 27, 2021

Kaltura cashes $150m in IPO

The Mitsui and Intel-backed video software developer has a market capitalisation of almos $1.5bn following its initial public offering last week.

Jul 26, 2021

Byju’s buys Epic for $500m

Rakuten is exiting the online reading platform developer in a $500m acquisition by online education provider Byju’s following $50m in funding.

Jul 26, 2021

AbSci nabs $200m in initial public offering

AGC, JSR Life Sciences and Merck & Co all scored exits as the synthetic biology technology developer floated on Nasdaq, whose valuation reportedly stands at nearly $2bn.

Jul 26, 2021

ChargePoint says yes to Has.to.Be acquisition

ChargePoint has agreed to pay $294m to acquire the EV charging station management platform, two years after the latter secured an undisclosed amount from Volkswagen.

Jul 26, 2021

Daily Deal Round Up: July 23, 2021

Branding services provider Tailor Brands raised $50m in a GoDaddy-led series C round while Orix is set to exit hiring software developer PandoLogic in a $150m acquisition.

Jul 23, 2021

Caribou Biosciences careers on to public markets

UC Berkeley’s cancer therapy developer priced a $304m initial public offering at the top of its range.

Jul 23, 2021

IsoPlexis applies itself to IPO filing

Yale University is in line to exit proteomics platform developer IsoPlexis in a Nasdaq Global Market offering with a $100m placeholder target.

Jul 23, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here